MENU
+Compare
IWINQ
Stock ticker: OTC
AS OF
Dec 3 closing price
Price
$0.21
Change
-$0.00 (-0.00%)
Capitalization
711.4K

IWINQ stock forecast, quote, news & analysis

Irwin Naturals Inc develops vitamins and other health supplements and distributes these products in the United States and Canada through two main channels: health food stores and mass market retailers... Show more

IWINQ
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for IWINQ with price predictions
Nov 28, 2025

IWINQ's RSI Oscillator descends into oversold zone

The RSI Oscillator for IWINQ moved into overbought territory on November 28, 2025. Be on the watch for a price drop or consolidation in the future -- when this happens, think about selling the stock or exploring put options.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis
Bearish Trend Analysis

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.099) is normal, around the industry mean (3.080). P/E Ratio (0.000) is within average values for comparable stocks, (42.226). IWINQ's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.283). Dividend Yield (0.000) settles around the average of (0.027) among similar stocks. P/S Ratio (0.008) is also within normal values, averaging (6.647).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IWINQ’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IWINQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 96, placing this stock worse than average.

A.I.Advisor
published Highlights

Industry description

The drugstore chains industry includes stores that sell medicines (both prescription and non-prescription), health, beauty and personal care products. Over time, many pharmacy retail chains have launched their own pharmacy benefits management services. Since demand for medical products is typically less sensitive to economic cycles, drugstore retail chains industry could be largely considered as non-cyclical. CVS Health Corporation, Walgreens Boots Alliance Inc. and Rite Aid Corporation are some of the biggest operators in this industry.

Market Cap

The average market capitalization across the Drugstore Chains Industry is 3.6B. The market cap for tickers in the group ranges from 3.29K to 24.7B. JDHIF holds the highest valuation in this group at 24.7B. The lowest valued company is RLLVF at 3.29K.

High and low price notable news

The average weekly price growth across all stocks in the Drugstore Chains Industry was -2%. For the same Industry, the average monthly price growth was -3%, and the average quarterly price growth was 13%. PETS experienced the highest price growth at 7%, while HKPD experienced the biggest fall at -23%.

Volume

The average weekly volume growth across all stocks in the Drugstore Chains Industry was -52%. For the same stocks of the Industry, the average monthly volume growth was -96% and the average quarterly volume growth was -28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 55
P/E Growth Rating: 71
Price Growth Rating: 65
SMR Rating: 77
Profit Risk Rating: 95
Seasonality Score: 3 (-100 ... +100)
View a ticker or compare two or three
IWINQ
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry DrugstoreChains

Profile
Fundamentals
Details